Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis

PLoS Pathogens

Volumn 9, Issue 3, 2013, Pages

  Berri, Fatma ^a   Rimmelzwaan, Guus F ^b   Hanss, Michel ^c   Albina, Emmanuel ^d,e   Foucault Grunenwald, Marie Laure ^a   Lê, Vuong B ^a   Vogelzang van Trierum, Stella E ^b   Gil, Patrica ^d,e   Camerer, Eric ^f,g   Martinez, Dominique ^d,e   Lina, Bruno ^a   Lijnen, Roger ^h   Carmeliet, Peter ^i,j   Riteau, Béatrice ^a,e  

^a UNIVERSITÉ LYON 1   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HOSPICES CIVILS DE LYON   (France)

^d UMR ASTRE   (France)

^e CEMAGREF   (France)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^j UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; GENE DELETION; IMMUNOHISTOCHEMISTRY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; LUNG INJURY; MALE; MOUSE; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; ANTIVIRAL AGENTS; FEMALE; FIBRIN; FIBRIN CLOT LYSIS TIME; FIBRINOGEN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HOST-PATHOGEN INTERACTIONS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; PLASMINOGEN; PNEUMONIA, VIRAL; VIRUS REPLICATION;

MUS; ORTHOMYXOVIRIDAE;

EID: 84876008810     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003229     Document Type: Article

References (49)

1. Knipe DM, Howley PM, editors (2006) Fields Virology. 5th edition. Philadelphia (Pennsylvania): Lippincott, Williams, & Wilkins.
2. Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF, (2012) Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2: 276-286.
3. La Gruta NL, Kedzierska K, Stambas J, Doherty PC, (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85: 85-92.
4. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
5. Reed CE, Kita H, (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114: 997-1008; quiz 1009.
6. Sokolova E, Reiser G, (2007) A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors. Pharmacol Ther 115: 70-83.
7. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, et al. (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26: 1-43.
8. Bradley LM, Douglass MF, Chatterjee D, Akira S, Baaten BJ, (2012) Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog 8: e1002641.
9. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, et al. (2013) PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 123: 206-214.
10. LeBouder F, Morello E, Rimmelzwaan GF, Bosse F, Pechoux C, et al. (2008) Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol 82: 6820-6828.
11. LeBouder F, Lina B, Rimmelzwaan GF, Riteau B, (2010) Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J Gen Virol 91: 2753-2761.
12. Goto H, Kawaoka Y, (1998) A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A 95: 10224-10228.
13. Goto H, Wells K, Takada A, Kawaoka Y, (2001) Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. J Virol 75: 9297-9301.
14. van Hinsbergh VW, (2012) Endothelium-role in regulation of coagulation and inflammation. Semin Immunopathol 34: 93-106.
15. Keller TT, van der Sluijs KF, de Kruif MD, Gerdes VE, Meijers JC, et al. (2006) Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 99: 1261-1269.
16. Manz B, Brunotte L, Reuther P, Schwemmle M, (2012) Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat Commun 3: 802.
17. Prentice C, (1980) Basis of antifibrinolytic therapy. J Clin Pathol 33: 35-40.
18. Gong Y, Hart E, Shchurin A, Hoover-Plow J, (2008) Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 118: 3012-3024.
19. Wygrecka M, Marsh LM, Morty RE, Henneke I, Guenther A, et al. (2009) Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 113: 5588-5598.
20. Syrovets T, Tippler B, Rieks M, Simmet T, (1997) Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood 89: 4574-4583.
21. O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM, (2010) S100A10 regulates plasminogen-dependent macrophage invasion. Blood 116: 1136-1146.
22. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF, (1998) Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 91: 2005-2009.
23. Moons L, Shi C, Ploplis V, Plow E, Haber E, et al. (1998) Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest 102: 1788-1797.
24. Soepandi PZ, Burhan E, Mangunnegoro H, Nawas A, Aditama TY, et al. (2010) Clinical course of avian influenza A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest 138: 665-673.
25. Wang ZF, Su F, Lin XJ, Dai B, Kong LF, et al. (2011) Serum D-dimer changes and prognostic implication in 2009 novel influenza A(H1N1). Thromb Res 127: 198-201.
26. Urso R, Bevilacqua N, Gentile M, Biagioli D, Lauria FN, (2011) Pandemic 2009 H1N1 virus infection associated with purpuric skin lesions: a case report. J Med Case Reports 5: 132.
27. Okayama S, Arakawa S, Ogawa K, Makino T, (2011) A case of hemorrhagic colitis after influenza A infection. J Microbiol Immunol Infect 44 (6):: 480-483.
28. Degen JL, Bugge TH, Goguen JD, (2007) Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 5 (Suppl 1):: 24-31.
29. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, et al. (2011) Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection. Cell 146: 980-991.
30. Fislova T, Gocnik M, Sladkova T, Durmanova V, Rajcani J, et al. (2009) Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol 154: 409-419.
31. Sanchez-Lanier M, Davis LE, Blisard KS, Woodfin BM, Wallace JM, et al. (1991) Influenza A virus in the mouse: hepatic and cerebral lesions in a Reye's syndrome-like illness. Int J Exp Pathol 72: 489-500.
32. Sun X, Tse LV, Ferguson AD, Whittaker GR, (2010) Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J Virol 84: 8683-8690.
33. Zhirnov OP, Ikizler MR, Wright PF, (2002) Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol 76: 8682-8689.
34. Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, et al. (2010) TMPRSS2 and TMPRSS4 facilitate trypsin-independent influenza virus spread in Caco-2 cells. J Virol 84: 10016-10025.
35. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, et al. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80: 9896-9898.
36. Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I, et al. (2009) Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 83: 3200-3211.
37. Zhirnov OP, Klenk HD, Wright PF, (2011) Aprotinin and similar protease inhibitors as drugs against influenza. Antiviral Res 92: 27-36.
38. Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, et al. (2010) Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 84: 5605-5614.
39. Zhirnov OP, Ovcharenko AV, Bukrinskaya AG, (1982) Protective effect of protease inhibitors in influenza virus infected animals. Arch Virol 73: 263-272.
40. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
41. Couacy-Hymann E, Danho T, Keita D, Bodjo SC, Kouakou C, et al. (2009) The first specific detection of a highly pathogenic avian influenza virus (H5N1) in Ivory Coast. Zoonoses Public Health 56: 10-15.
42. Hanss MM, Ffrench PO, Mornex JF, Chabuet M, Biot F, et al. (2003) Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J Thromb Haemost 1: 1251-1257.
43. Luyendyk JP, Sullivan BP, Guo GL, Wang R, (2010) Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol 176: 177-186.
44. Bernard D, Riteau B, Hansen JD, Phillips RB, Michel F, et al. (2006) Costimulatory receptors in a teleost fish: typical CD28, elusive CTLA4. J Immunol 176: 4191-4200.
45. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, et al. (1995) Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 92: 2585-2593.
46. Riteau B, Moreau P, Menier C, Khalil-Daher I, Khosrotehrani K, et al. (2001) Characterization of HLA-G1,-G2,-G3, and-G4 isoforms transfected in a human melanoma cell line. Transplant Proc 33: 2360-2364.
47. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, et al. (2009) Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 182: 7795-7802.
48. LeBouder F, Khoufache K, Menier C, Mandouri Y, Keffous M, et al. (2009) Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum Immunol 70: 1016-1019.
49. Riteau B, Faure F, Menier C, Viel S, Carosella ED, et al. (2003) Exosomes bearing HLA-G are released by melanoma cells. Hum Immunol 64: 1064-1072.